{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:31:22Z","timestamp":1762867882961,"version":"3.37.3"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T00:00:00Z","timestamp":1561334400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T00:00:00Z","timestamp":1561334400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","award":["70112082"],"award-info":[{"award-number":["70112082"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s10549-019-05327-4","type":"journal-article","created":{"date-parts":[[2019,7,27]],"date-time":"2019-07-27T09:02:31Z","timestamp":1564218151000},"page":"457-467","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Non-sentinel axillary tumor burden applying the ACOSOG Z0011 eligibility criteria to a large routine cohort"],"prefix":"10.1007","volume":"177","author":[{"given":"Fabian","family":"Riedel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"Heil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Fei\u00dft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahdi","family":"Rezai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mareike","family":"Moderow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christof","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Sch\u00fctz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Golatta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9","family":"Hennigs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,24]]},"reference":[{"issue":"4","key":"5327_CR1","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1056\/NEJMoa1415340","volume":"373","author":"TJ Whelan","year":"2015","unstructured":"Whelan TJ, Olivotto IA, Parulekar WR, Ackerman I, Chua BH, Nabid A et al (2015) Regional nodal irradiation in early-stage breast cancer. N Engl J Med 373(4):307\u2013316","journal-title":"N Engl J Med"},{"issue":"17","key":"5327_CR2","doi-asserted-by":"publisher","first-page":"2874","DOI":"10.1200\/JCO.2009.24.7643","volume":"28","author":"V Moebus","year":"2010","unstructured":"Moebus V, Jackisch C, Lueck HJ, du Bois A, Thomssen C, Kurbacher C et al (2010) Intense dose-dense sequential chemotherapy with epirubicin, paclitaxel, and cyclophosphamide compared with conventionally scheduled chemotherapy in high-risk primary breast cancer: mature results of an AGO phase III study. J Clin Oncol 28(17):2874\u20132880","journal-title":"J Clin Oncol"},{"key":"5327_CR3","unstructured":"Network NCC (2016) NCCN clinical practice guidelines in oncology (NCCN Guidelines). Breast Cancer 2016. 1"},{"issue":"6797","key":"5327_CR4","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA et al (2000) Molecular portraits of human breast tumours. Nature 406(6797):747\u2013752","journal-title":"Nature"},{"issue":"8","key":"5327_CR5","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1056\/NEJMoa1602253","volume":"375","author":"F Cardoso","year":"2016","unstructured":"Cardoso F, van\u2019t Veer LJ, Bogaerts J, Slaets L, Viale G, Delaloge S et al (2016) 70-gene signature as an aid to treatment decisions in early-stage breast cancer. N Engl J Med 375(8):717\u2013729","journal-title":"N Engl J Med"},{"issue":"20","key":"5327_CR6","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1200\/JCO.2015.63.5383","volume":"34","author":"O Gluz","year":"2016","unstructured":"Gluz O, Nitz UA, Christgen M, Kates RE, Shak S, Clemens M et al (2016) West German Study Group Phase III PlanB trial: first prospective outcome data for the 21-gene recurrence score assay and concordance of prognostic markers by central and local pathology assessment. J Clin Oncol 34(20):2341\u20132349","journal-title":"J Clin Oncol"},{"issue":"6","key":"5327_CR7","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1056\/NEJMoa012782","volume":"349","author":"U Veronesi","year":"2003","unstructured":"Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V et al (2003) A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349(6):546\u2013553","journal-title":"N Engl J Med"},{"issue":"10","key":"5327_CR8","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","volume":"11","author":"DN Krag","year":"2010","unstructured":"Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP et al (2010) Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 11(10):927\u2013933","journal-title":"Lancet Oncol"},{"issue":"6","key":"5327_CR9","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/S1470-2045(13)70076-7","volume":"14","author":"T DiSipio","year":"2013","unstructured":"DiSipio T, Rye S, Newman B, Hayes S (2013) Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol 14(6):500\u2013515","journal-title":"Lancet Oncol"},{"issue":"3","key":"5327_CR10","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/SLA.0b013e3181f08f32","volume":"252","author":"AE Giuliano","year":"2010","unstructured":"Giuliano AE, McCall L, Beitsch P, Whitworth PW, Blumencranz P, Leitch AM et al (2010) Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg 252(3):426\u2013432 (discussion 32-3)","journal-title":"Ann Surg"},{"issue":"3","key":"5327_CR11","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/SLA.0000000000001863","volume":"264","author":"AE Giuliano","year":"2016","unstructured":"Giuliano AE, Ballman K, McCall L, Beitsch P, Whitworth PW, Blumencranz P et al (2016) Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: long-term follow-up from the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 randomized trial. Ann Surg 264(3):413\u2013420","journal-title":"Ann Surg"},{"issue":"10","key":"5327_CR12","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1001\/jama.2017.11470","volume":"318","author":"AE Giuliano","year":"2017","unstructured":"Giuliano AE, Ballman KV, McCall L, Beitsch PD, Brennan MB, Kelemen PR et al (2017) Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial. JAMA 318(10):918\u2013926","journal-title":"JAMA"},{"issue":"8","key":"5327_CR13","doi-asserted-by":"publisher","first-page":"791","DOI":"10.5858\/arpa.2015-0140-RA","volume":"140","author":"A Maguire","year":"2016","unstructured":"Maguire A, Brogi E (2016) Sentinel lymph nodes for breast carcinoma: a paradigm shift. Arch Pathol Lab Med 140(8):791\u2013798","journal-title":"Arch Pathol Lab Med"},{"issue":"8","key":"5327_CR14","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.ejso.2012.04.018","volume":"38","author":"U Guth","year":"2012","unstructured":"Guth U, Myrick ME, Viehl CT, Schmid SM, Obermann EC, Weber WP (2012) The post ACOSOG Z0011 era: does our new understanding of breast cancer really change clinical practice? Eur J Surg Oncol 38(8):645\u2013650","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"5327_CR15","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1177\/107327481201900403","volume":"19","author":"M Shah-Khan","year":"2012","unstructured":"Shah-Khan M, Boughey JC (2012) Evolution of axillary nodal staging in breast cancer: clinical implications of the ACOSOG Z0011 trial. Cancer Control 19(4):267\u2013276","journal-title":"Cancer Control"},{"issue":"9","key":"5327_CR16","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1245\/s10434-011-1857-2","volume":"18","author":"M Morrow","year":"2011","unstructured":"Morrow M, Giuliano AE (2011) To cut is to cure: can we really apply Z11 in practice? Ann Surg Oncol 18(9):2413\u20132415","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"5327_CR17","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S1470-2045(13)70035-4","volume":"14","author":"V Galimberti","year":"2013","unstructured":"Galimberti V, Cole BF, Zurrida S, Viale G, Luini A, Veronesi P et al (2013) Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial. Lancet Oncol 14(4):297\u2013305","journal-title":"Lancet Oncol"},{"issue":"10","key":"5327_CR18","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/S1470-2045(18)30380-2","volume":"19","author":"V Galimberti","year":"2018","unstructured":"Galimberti V, Cole BF, Viale G, Veronesi P, Vicini E, Intra M et al (2018) Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial. Lancet Oncol 19(10):1385\u20131393","journal-title":"Lancet Oncol"},{"issue":"12","key":"5327_CR19","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","volume":"15","author":"M Donker","year":"2014","unstructured":"Donker M, van Tienhoven G, Straver ME, Meijnen P, van de Velde CJ, Mansel RE et al (2014) Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol 15(12):1303\u20131310","journal-title":"Lancet Oncol"},{"issue":"4","key":"5327_CR20","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.ejso.2016.12.011","volume":"43","author":"A Savolt","year":"2017","unstructured":"Savolt A, Peley G, Polgar C, Udvarhelyi N, Rubovszky G, Kovacs E et al (2017) Eight-year follow up result of the OTOASOR trial: the Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: a randomized, single centre, phase III, non-inferiority trial. Eur J Surg Oncol 43(4):672\u2013679","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"5327_CR21","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s00404-018-4982-3","volume":"299","author":"F Riedel","year":"2018","unstructured":"Riedel F, Heil J, Golatta M, Schaefgen B, Hug S, Schott S et al (2018) Changes of breast and axillary surgery patterns in patients with primary breast cancer during the past decade. Arch Gynecol Obstet 299(4):1043\u20131053","journal-title":"Arch Gynecol Obstet"},{"issue":"10","key":"5327_CR22","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1055\/a-0646-4522","volume":"78","author":"A Wockel","year":"2018","unstructured":"Wockel A, Festl J, Stuber T, Brust K, Stangl S, Heuschmann PU et al (2018) Interdisciplinary screening, diagnosis, therapy and follow-up of breast cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032\/045OL, December 2017) - Part 1 with Recommendations for the Screening, Diagnosis and Therapy of Breast Cancer. Geburtshilfe Frauenheilkd 78(10):927\u2013948","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"4","key":"5327_CR23","doi-asserted-by":"publisher","first-page":"433","DOI":"10.6004\/jnccn.2017.0044","volume":"15","author":"WJ Gradishar","year":"2017","unstructured":"Gradishar WJ, Anderson BO, Balassanian R, Blair SL, Burstein HJ, Cyr A et al (2017) NCCN guidelines insights: breast cancer, version 1.2017. J Natl Compr Cancer Netw 15(4):433\u2013451","journal-title":"J Natl Compr Cancer Netw"},{"key":"5327_CR24","unstructured":"WBC, Westdeutsches Brust-Centrum GmbH (2015) Benchmarking WBC - 2014, Jahresbericht, Kennzahlen"},{"issue":"2","key":"5327_CR25","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s10549-018-5009-2","volume":"173","author":"A Hennigs","year":"2019","unstructured":"Hennigs A, Kopke M, Feisst M, Riedel F, Rezai M, Nitz U et al (2019) Which patients with sentinel node-positive breast cancer after breast conservation still receive completion axillary lymph node dissection in routine clinical practice? Breast Cancer Res Treat 173(2):429\u2013438","journal-title":"Breast Cancer Res Treat"},{"issue":"8","key":"5327_CR26","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1093\/annonc\/mdr304","volume":"22","author":"A Goldhirsch","year":"2011","unstructured":"Goldhirsch A, Wood WC, Coates AS, Gelber RD, Thurlimann B, Senn HJ (2011) Strategies for subtypes\u2013dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol 22(8):1736\u20131747","journal-title":"Ann Oncol"},{"issue":"1","key":"5327_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-016-2766-3","volume":"16","author":"A Hennigs","year":"2016","unstructured":"Hennigs A, Riedel F, Gondos A, Sinn P, Schirmacher P, Marm\u00e9 F et al (2016) Prognosis of breast cancer molecular subtypes in routine clinical care: a large prospective cohort study. BMC Cancer 16(1):1\u20139","journal-title":"BMC Cancer"},{"issue":"1","key":"5327_CR28","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1245\/s10434-013-3200-6","volume":"21","author":"LT Dengel","year":"2014","unstructured":"Dengel LT, Van Zee KJ, King TA, Stempel M, Cody HS, El-Tamer M et al (2014) Axillary dissection can be avoided in the majority of clinically node-negative patients undergoing breast-conserving therapy. Ann Surg Oncol 21(1):22\u201327","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"5327_CR29","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jamcollsurg.2015.02.035","volume":"221","author":"K Yao","year":"2015","unstructured":"Yao K, Liederbach E, Pesce C, Wang CH, Winchester DJ (2015) Impact of the American College of Surgeons Oncology Group Z0011 randomized trial on the number of axillary nodes removed for patients with early-stage breast cancer. J Am Coll Surg 221(1):71\u201381","journal-title":"J Am Coll Surg"},{"issue":"6","key":"5327_CR30","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1097\/SLA.0000000000002440","volume":"268","author":"IGM Poodt","year":"2018","unstructured":"Poodt IGM, Spronk PER, Vugts G, van Dalen T, Peeters M, Rots ML et al (2018) Trends on axillary surgery in nondistant metastatic breast cancer patients treated between 2011 and 2015: a Dutch Population-based Study in the ACOSOG-Z0011 and AMAROS Era. Ann Surg 268(6):1084\u20131090","journal-title":"Ann Surg"},{"issue":"6","key":"5327_CR31","doi-asserted-by":"publisher","first-page":"712","DOI":"10.3109\/0284186X.2015.1136751","volume":"55","author":"A Gondos","year":"2016","unstructured":"Gondos A, Jansen L, Heil J, Schneeweiss A, Voogd AC, Frisell J et al (2016) Time trends in axilla management among early breast cancer patients: persisting major variation in clinical practice across European centers. Acta Oncol 55(6):712\u2013719","journal-title":"Acta Oncol"},{"issue":"2","key":"5327_CR32","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.surge.2016.07.002","volume":"15","author":"K Naidoo","year":"2017","unstructured":"Naidoo K, Pinder SE (2017) Micro- and macro-metastasis in the axillary lymph node: a review. Surgeon 15(2):76\u201382","journal-title":"Surgeon"},{"key":"5327_CR33","unstructured":"Bauerfeind I, K\u00fcmmel S. (Working Group Gynecological Oncology) (2011) Diagnosis and treatment of patients with primary and metastatic breast cancer: Guidelines of the AGO Breast Commission. 03\/2011"},{"issue":"1","key":"5327_CR34","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jamcollsurg.2012.09.005","volume":"216","author":"M Yi","year":"2013","unstructured":"Yi M, Kuerer HM, Mittendorf EA, Hwang RF, Caudle AS, Bedrosian I et al (2013) Impact of the American College of Surgeons Oncology Group Z0011 criteria applied to a contemporary patient population. J Am Coll Surg 216(1):105\u2013113","journal-title":"J Am Coll Surg"},{"issue":"10","key":"5327_CR35","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.1245\/s10434-016-5310-4","volume":"23","author":"MW Tsao","year":"2016","unstructured":"Tsao MW, Cornacchi SD, Hodgson N, Simunovic M, Thabane L, Cheng J et al (2016) A population-based study of the effects of a regional guideline for completion axillary lymph node dissection on axillary surgery in patients with breast cancer. Ann Surg Oncol 23(10):3354\u20133364","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"5327_CR36","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/tbj.12276","volume":"20","author":"GM Freedman","year":"2014","unstructured":"Freedman GM, Fowble BL, Li T, Hwang ES, Schechter N, Devarajan K et al (2014) Risk of positive nonsentinel nodes in women with 1-2 positive sentinel nodes related to age and molecular subtype approximated by receptor status. Breast J 20(4):358\u2013363","journal-title":"Breast J"},{"issue":"28","key":"5327_CR37","doi-asserted-by":"publisher","first-page":"4701","DOI":"10.1200\/JCO.2008.21.7075","volume":"27","author":"EK Millar","year":"2009","unstructured":"Millar EK, Graham PH, O\u2019Toole SA, McNeil CM, Browne L, Morey AL et al (2009) Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel. J Clin Oncol 27(28):4701\u20134708","journal-title":"J Clin Oncol"},{"issue":"10","key":"5327_CR38","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1245\/s10434-009-0606-2","volume":"16","author":"L Wiechmann","year":"2009","unstructured":"Wiechmann L, Sampson M, Stempel M, Jacks LM, Patil SM, King T et al (2009) presenting features of breast cancer differ by molecular subtype. Ann Surg Oncol 16(10):2705\u20132710","journal-title":"Ann Surg Oncol"},{"issue":"13","key":"5327_CR39","doi-asserted-by":"publisher","first-page":"4098","DOI":"10.1245\/s10434-014-3989-7","volume":"21","author":"A Gangi","year":"2014","unstructured":"Gangi A, Mirocha J, Leong T, Giuliano AE (2014) Triple-negative breast cancer is not associated with increased likelihood of nodal metastases. Ann Surg Oncol 21(13):4098\u20134103","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"5327_CR40","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/S1470-2045(16)00163-7","volume":"17","author":"L Gianni","year":"2016","unstructured":"Gianni L, Pienkowski T, Im YH, Tseng LM, Liu MC, Lluch A et al (2016) 5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 randomised trial. Lancet Oncol 17(6):791\u2013800","journal-title":"Lancet Oncol"},{"issue":"3","key":"5327_CR41","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s10549-016-4016-4","volume":"160","author":"A Hennigs","year":"2016","unstructured":"Hennigs A, Riedel F, Marme F, Sinn P, Lindel K, Gondos A et al (2016) Changes in chemotherapy usage and outcome of early breast cancer patients in the last decade. Breast Cancer Res Treat 160(3):491\u2013499","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"5327_CR42","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.clbc.2013.04.004","volume":"13","author":"A Savolt","year":"2013","unstructured":"Savolt A, Polgar C, Musonda P, Matrai Z, Renyi-Vamos F, Toth L et al (2013) Does the result of completion axillary lymph node dissection influence the recommendation for adjuvant treatment in sentinel lymph node-positive patients? Clin Breast Cancer 13(5):364\u2013370","journal-title":"Clin Breast Cancer"},{"issue":"8","key":"5327_CR43","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.ejso.2018.03.003","volume":"44","author":"IGM Poodt","year":"2018","unstructured":"Poodt IGM, Rots ML, Vugts G, van Dalen T, Kuijer A, Vriens BEPJ et al (2018) The administration of adjuvant chemo(-immuno) therapy in the post ACOSOG-Z0011 era; a population based study. Eur J Surg Oncol 44(8):1151\u20131156","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"5327_CR44","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1245\/s10434-012-2798-0","volume":"20","author":"J Aigner","year":"2013","unstructured":"Aigner J, Smetanay K, Hof H, Sinn HP, Sohn C, Schneeweiss A et al (2013) Omission of axillary dissection according to ACOSOG Z0011: impact on adjuvant treatment recommendations. Ann Surg Oncol 20(5):1538\u20131544","journal-title":"Ann Surg Oncol"},{"issue":"24","key":"5327_CR45","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1200\/JCO.2006.07.4062","volume":"25","author":"A Lucci","year":"2007","unstructured":"Lucci A, McCall LM, Beitsch PD, Whitworth PW, Reintgen DS, Blumencranz PW et al (2007) Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol 25(24):3657\u20133663","journal-title":"J Clin Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-019-05327-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-019-05327-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-019-05327-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T18:43:59Z","timestamp":1664045039000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-019-05327-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,24]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["5327"],"URL":"https:\/\/doi.org\/10.1007\/s10549-019-05327-4","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"type":"print","value":"0167-6806"},{"type":"electronic","value":"1573-7217"}],"subject":[],"published":{"date-parts":[[2019,6,24]]},"assertion":[{"value":"10 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"There are no conflicts of interests (e.g., employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications\/registrations or grants or other funding) with regard to this study for any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the ethics committee of the University of Heidelberg and was conducted in accordance with the Declaration of Helsinki. The study was deemed to be without risk, including only anonymized analysis of routinely collected data; consequently, the ethics committee of the University of University did not request approval for consent for this designated analysis.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants within the data acquisition of the benchmarking process.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}